Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Jun 17;11(6):e4919.
doi: 10.7759/cureus.4919.

Oncogenic Osteomalacia with Elevated Fibroblast Growth Factor 23: A Rare Case of Paranasal Sinus Tumor Onset

Affiliations
Case Reports

Oncogenic Osteomalacia with Elevated Fibroblast Growth Factor 23: A Rare Case of Paranasal Sinus Tumor Onset

Mario Rigante et al. Cureus. .

Abstract

Tumor-induced osteomalacia, also known as oncogenic osteomalacia, is a rare, acquired paraneoplastic disease characterized by hypophosphatemia and renal phosphate wasting. We report on the case of a 52-year-old-man admitted to our hospital for bone and muscular pains and difficulty in walking. He underwent a computed tomography (CT) scan of the legs that documented fractures in the right tibia, femur, and fifth metatarsus. Laboratory findings showed hypophosphatemia and elevated levels of parathyroid hormone (PTH). The first diagnosis was osteomalacia, treated with calcium and vitamin D, without any benefit. So he underwent a whole body CT scan, showing a small expansive lesion occupying the left frontal sinus. Furthermore, we found high serum levels of fibroblast growth factor 23 (FGF23) using the enzyme-linked immune sorbent assay (ELISA) assay. The patient underwent endoscopic surgical resection of the frontal tumor with complete clinical remission and the histopathological diagnosis of an ossifying fibromyxoid tumor. This is a rare case of oncogenic osteomalacia due to a paranasal sinus tumor. The main symptoms are not associated with nasal sinus involvement but with over-expressed FGF23. To conclude, physicians should never underestimate the chance of paraneoplastic syndrome in the head and neck district, even if such an occurrence is uncommon in this location. The clinical symptoms may be aspecific and not related to nose problems, making the differential diagnosis very difficult.

Keywords: fibroblast growth factor 23; hypophosphatemia; oncogenic osteomalacia; ossifying fibromyxoid tumor; paranasal sinus tumor.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Whole Body FDG-PET/CT
Evidence of a small lesion in the left frontal sinus with intense FDG uptake compatible with the recurrence of a bone lesion FDG-PET/CT: 18F-fluorodeoxyglucose positron emission tomography-computed tomography
Figure 2
Figure 2. MRI T2-Weighted with Contrast
Evidence of a 7 mm mass protruding in the left frontal sinus MRI: magnetic resonance imaging
Figure 3
Figure 3. Endoscopic Frontal Sinus Surgery
Endoscopic appearance of the smooth non-ulcerated lesion originating from the posterior wall of the frontal sinus
Figure 4
Figure 4. Histopathology Report
Histopathologic images showing the cell neoplasm constituted by small, round, and oval elements, with mild nuclear pleomorphism and scant cytoplasm immersed in the stroma with abundant collagen, a chondroid pattern in some areas, and osteoid formation.

References

    1. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature. Hu FK, Yuan F, Jiang CY, et al. Chin J Cancer. 2011;30:794–804. - PMC - PubMed
    1. Fibroblast growth factor 23 and its role in phosphate homeostasis. Ramon I, Kleynen P, Body JJ, Karmali R. Eur J Endocrinol. 2010;162:1–10. - PubMed
    1. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Folpe AL, FanburgSmith JC, Billings SD, et al. https://journals.lww.com/ajsp/Fulltext/2004/01000/Most_Osteomalacia_asso.... Am J Surg Pathol. 2004;28:1–30. - PubMed
    1. Oncogenic osteomalacia induced by a sinonasal tumour: case report and review. Kabtouri H, Karmali R, Spinato L, Khamaktchian M, Bisschop P. https://www.researchgate.net/publication/264502917_Oncogenic_osteomalaci.... B-ENT. 2014;10:149–155. - PubMed
    1. Sinonasal phosphaturic mesenchymal tumor: a rare and misinterpreted entity. Arnaoutakis D, Naseri I. J Neurol Surg Rep. 2015;76:233–238. - PMC - PubMed

Publication types

LinkOut - more resources